Literature DB >> 23871672

Cracking the molecular origin of intrinsic tyrosine kinase activity through analysis of pathogenic gain-of-function mutations.

Huaibin Chen1, Zhifeng Huang, Kaushik Dutta, Steven Blais, Thomas A Neubert, Xiaokun Li, David Cowburn, Nathaniel J Traaseth, Moosa Mohammadi.   

Abstract

The basal (ligand-independent) kinase activity of receptor tyrosine kinases (RTKs) promotes trans-phosphorylation on activation loop tyrosines upon ligand-induced receptor dimerization, thus upregulating intrinsic kinase activity and triggering intracellular signaling. To understand the molecular determinants of intrinsic kinase activity, we used X-ray crystallography and NMR spectroscopy to analyze pathogenic FGF receptor mutants with gradations in gain-of-function activity. These structural analyses revealed a "two-state" dynamic equilibrium model whereby the kinase toggles between an "inhibited," structurally rigid ground state and a more dynamic and heterogeneous active state. The pathogenic mutations have different abilities to shift this equilibrium toward the active state. The increase in the fractional population of FGF receptors in the active state correlates with the degree of gain-of-function activity and clinical severity. Our data demonstrate that the fractional population of RTKs in the active state determines intrinsic kinase activity and underscore how a slight increase in the active population of kinases can have grave consequences for human health.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23871672      PMCID: PMC3752781          DOI: 10.1016/j.celrep.2013.06.025

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  35 in total

Review 1.  Allosteric protein kinase regulation by pseudokinases: insights from STRAD.

Authors:  Thanashan Rajakulendran; Frank Sicheri
Journal:  Sci Signal       Date:  2010-03-02       Impact factor: 8.192

2.  Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia.

Authors:  C P Chen; S R Chern; J C Shih; W Wang; L F Yeh; T Y Chang; C Y Tzen
Journal:  Prenat Diagn       Date:  2001-02       Impact factor: 3.050

Review 3.  Protein tyrosine kinase structure and function.

Authors:  S R Hubbard; J H Till
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 4.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 5.  The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.

Authors:  Z Vajo; C A Francomano; D J Wilkin
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

6.  Flexibility and charge asymmetry in the activation loop of Src tyrosine kinases.

Authors:  Nilesh K Banavali; Benoît Roux
Journal:  Proteins       Date:  2009-02-01

7.  Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: a novel class of receptor tyrosine kinase inhibitors.

Authors:  Paul A Renhowe; Sabina Pecchi; Cynthia M Shafer; Timothy D Machajewski; Elisa M Jazan; Clarke Taylor; William Antonios-McCrea; Christopher M McBride; Kelly Frazier; Marion Wiesmann; Gena R Lapointe; Paul H Feucht; Robert L Warne; Carla C Heise; Daniel Menezes; Kimberly Aardalen; Helen Ye; Molly He; Vincent Le; Jayesh Vora; Johanna M Jansen; Mary Ellen Wernette-Hammond; Alex L Harris
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

8.  A crystallographic snapshot of tyrosine trans-phosphorylation in action.

Authors:  Huaibin Chen; Chong-Feng Xu; Jinghong Ma; Anna V Eliseenkova; Wanqing Li; Pamela M Pollock; Nelly Pitteloud; W Todd Miller; Thomas A Neubert; Moosa Mohammadi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-05       Impact factor: 11.205

9.  Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes.

Authors:  P M Pollock; M G Gartside; L C Dejeza; M A Powell; M A Mallon; H Davies; M Mohammadi; P A Futreal; M R Stratton; J M Trent; P J Goodfellow
Journal:  Oncogene       Date:  2007-05-21       Impact factor: 9.867

10.  Drug-sensitive FGFR2 mutations in endometrial carcinoma.

Authors:  Amit Dutt; Helga B Salvesen; Tzu-Hsiu Chen; Alex H Ramos; Robert C Onofrio; Charlie Hatton; Richard Nicoletti; Wendy Winckler; Rupinder Grewal; Megan Hanna; Nicolas Wyhs; Liuda Ziaugra; Daniel J Richter; Jone Trovik; Ingeborg B Engelsen; Ingunn M Stefansson; Tim Fennell; Kristian Cibulskis; Michael C Zody; Lars A Akslen; Stacey Gabriel; Kwok-Kin Wong; William R Sellers; Matthew Meyerson; Heidi Greulich
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-13       Impact factor: 11.205

View more
  17 in total

1.  FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Yvette W Jeske; Shamshad Ali; Sara A Byron; Feng Gao; Robert S Mannel; Rahel G Ghebre; Paul A DiSilvestro; Shashikant B Lele; Michael L Pearl; Amy P Schmidt; Heather A Lankes; Nilsa C Ramirez; Golnar Rasty; Matthew Powell; Paul J Goodfellow; Pamela M Pollock
Journal:  Gynecol Oncol       Date:  2017-03-15       Impact factor: 5.482

2.  A Conserved Allosteric Pathway in Tyrosine Kinase Regulation.

Authors:  William M Marsiglia; Joseph Katigbak; Sijin Zheng; Moosa Mohammadi; Yingkai Zhang; Nathaniel J Traaseth
Journal:  Structure       Date:  2019-06-13       Impact factor: 5.006

3.  Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ.

Authors:  Zhifeng Huang; William M Marsiglia; Upal Basu Roy; Nader Rahimi; Dariush Ilghari; Huiyan Wang; Huaibin Chen; Weiming Gai; Steven Blais; Thomas A Neubert; Alka Mansukhani; Nathaniel J Traaseth; Xiaokun Li; Moosa Mohammadi
Journal:  Mol Cell       Date:  2015-12-10       Impact factor: 17.970

4.  Correlation of chemical shifts predicted by molecular dynamics simulations for partially disordered proteins.

Authors:  Jerome M Karp; Ertan Eryilmaz; Ertan Erylimaz; David Cowburn
Journal:  J Biomol NMR       Date:  2014-11-22       Impact factor: 2.835

5.  Oncogenic RET kinase domain mutations perturb the autophosphorylation trajectory by enhancing substrate presentation in trans.

Authors:  Iván Plaza-Menacho; Karin Barnouin; Kerry Goodman; Rubén J Martínez-Torres; Annabel Borg; Judith Murray-Rust; Stephane Mouilleron; Phillip Knowles; Neil Q McDonald
Journal:  Mol Cell       Date:  2014-02-20       Impact factor: 17.970

6.  Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation.

Authors:  Lingfeng Chen; William M Marsiglia; Huaibin Chen; Joseph Katigbak; Hediye Erdjument-Bromage; David J Kemble; Lili Fu; Jinghong Ma; Gongqin Sun; Yingkai Zhang; Guang Liang; Thomas A Neubert; Xiaokun Li; Nathaniel J Traaseth; Moosa Mohammadi
Journal:  Nat Chem Biol       Date:  2020-01-20       Impact factor: 15.040

7.  Structural mimicry of a-loop tyrosine phosphorylation by a pathogenic FGF receptor 3 mutation.

Authors:  Zhifeng Huang; Huaibin Chen; Steven Blais; Thomas A Neubert; Xiaokun Li; Moosa Mohammadi
Journal:  Structure       Date:  2013-08-22       Impact factor: 5.006

8.  KinView: a visual comparative sequence analysis tool for integrated kinome research.

Authors:  Daniel Ian McSkimming; Shima Dastgheib; Timothy R Baffi; Dominic P Byrne; Samantha Ferries; Steven Thomas Scott; Alexandra C Newton; Claire E Eyers; Krzysztof J Kochut; Patrick A Eyers; Natarajan Kannan
Journal:  Mol Biosyst       Date:  2016-11-15

9.  Ubiquitination switches EphA2 vesicular traffic from a continuous safeguard to a finite signalling mode.

Authors:  Ola Sabet; Rabea Stockert; Georgia Xouri; Yannick Brüggemann; Angel Stanoev; Philippe I H Bastiaens
Journal:  Nat Commun       Date:  2015-08-21       Impact factor: 14.919

10.  Excess centrosomes disrupt endothelial cell migration via centrosome scattering.

Authors:  Erich J Kushner; Luke S Ferro; Jie-Yu Liu; Jessica R Durrant; Stephen L Rogers; Andrew C Dudley; Victoria L Bautch
Journal:  J Cell Biol       Date:  2014-07-21       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.